Longer term effects of stimulant treatments for Attention-Deficit/ Hyperactivity Disorder

Peter Jensen

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Of pharmacological options available for Attention-Deficit/Hyperactivity Disorder (ADHD), stimulant medications are the most studied, the most commonly used, the most effective, and the first-line choice for treatment. Evidence of the short-term efficacy of methylphenidate (MPH) and other stimulants as well as behavioral treatments in the management of symptoms of ADHD is abundant. This paper reviews therapeutic trials with a duration or follow-up period of 12 months or more and evaluates the longer term outcomes of available treatments for ADHD. The trials were reported by lalongo et al. (1993), Horn et al. (1991), Schachar, Tannock, Cunningham, and Corkum (1997), Gillberg et al. (1997), Hechtman and Abikoff (1995), and the National Institute of Mental Health (MTA Cooperative Group, 1999a, 1999b).

Original languageEnglish (US)
JournalJournal of Attention Disorders
Volume6
Issue numberSUPPL. 1
StatePublished - 2002
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Pemetrexed
National Institute of Mental Health (U.S.)
Methylphenidate
Horns
Pharmacology
Therapeutics

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Longer term effects of stimulant treatments for Attention-Deficit/ Hyperactivity Disorder. / Jensen, Peter.

In: Journal of Attention Disorders, Vol. 6, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

@article{e8bc62948c5d4426b7957788064f6544,
title = "Longer term effects of stimulant treatments for Attention-Deficit/ Hyperactivity Disorder",
abstract = "Of pharmacological options available for Attention-Deficit/Hyperactivity Disorder (ADHD), stimulant medications are the most studied, the most commonly used, the most effective, and the first-line choice for treatment. Evidence of the short-term efficacy of methylphenidate (MPH) and other stimulants as well as behavioral treatments in the management of symptoms of ADHD is abundant. This paper reviews therapeutic trials with a duration or follow-up period of 12 months or more and evaluates the longer term outcomes of available treatments for ADHD. The trials were reported by lalongo et al. (1993), Horn et al. (1991), Schachar, Tannock, Cunningham, and Corkum (1997), Gillberg et al. (1997), Hechtman and Abikoff (1995), and the National Institute of Mental Health (MTA Cooperative Group, 1999a, 1999b).",
author = "Peter Jensen",
year = "2002",
language = "English (US)",
volume = "6",
journal = "Journal of Attention Disorders",
issn = "1087-0547",
publisher = "SAGE Publications Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Longer term effects of stimulant treatments for Attention-Deficit/ Hyperactivity Disorder

AU - Jensen, Peter

PY - 2002

Y1 - 2002

N2 - Of pharmacological options available for Attention-Deficit/Hyperactivity Disorder (ADHD), stimulant medications are the most studied, the most commonly used, the most effective, and the first-line choice for treatment. Evidence of the short-term efficacy of methylphenidate (MPH) and other stimulants as well as behavioral treatments in the management of symptoms of ADHD is abundant. This paper reviews therapeutic trials with a duration or follow-up period of 12 months or more and evaluates the longer term outcomes of available treatments for ADHD. The trials were reported by lalongo et al. (1993), Horn et al. (1991), Schachar, Tannock, Cunningham, and Corkum (1997), Gillberg et al. (1997), Hechtman and Abikoff (1995), and the National Institute of Mental Health (MTA Cooperative Group, 1999a, 1999b).

AB - Of pharmacological options available for Attention-Deficit/Hyperactivity Disorder (ADHD), stimulant medications are the most studied, the most commonly used, the most effective, and the first-line choice for treatment. Evidence of the short-term efficacy of methylphenidate (MPH) and other stimulants as well as behavioral treatments in the management of symptoms of ADHD is abundant. This paper reviews therapeutic trials with a duration or follow-up period of 12 months or more and evaluates the longer term outcomes of available treatments for ADHD. The trials were reported by lalongo et al. (1993), Horn et al. (1991), Schachar, Tannock, Cunningham, and Corkum (1997), Gillberg et al. (1997), Hechtman and Abikoff (1995), and the National Institute of Mental Health (MTA Cooperative Group, 1999a, 1999b).

UR - http://www.scopus.com/inward/record.url?scp=0141445134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141445134&partnerID=8YFLogxK

M3 - Article

VL - 6

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

SN - 1087-0547

IS - SUPPL. 1

ER -